Suppr超能文献

超越糖化血红蛋白的糖尿病足溃疡愈合多方面方法:在金奈一家三级护理医院进行的前瞻性观察研究

A Multifaceted Approach to Diabetic Foot Ulcer Healing Beyond HbA1c: A Prospective Observational Study in a Tertiary Care Hospital in Chennai.

作者信息

Selvaraj Mughilan, R G Santhaseelan

机构信息

General Surgery, Sree Balaji Medical College and Hospital, Chennai, IND.

出版信息

Cureus. 2025 Jul 17;17(7):e88136. doi: 10.7759/cureus.88136. eCollection 2025 Jul.

Abstract

BACKGROUND

Diabetic foot ulcers (DFUs) are among the most debilitating complications of diabetes mellitus, often leading to delayed healing, infections, and potential limb loss. While glycemic control, typically measured by HbA1c, has been a primary focus in DFU management, recent evidence suggests that healing outcomes are influenced by a broader range of factors.

OBJECTIVE

To evaluate the predictive role of clinical, biochemical, and inflammatory parameters beyond HbA1c in the healing of DFUs.

METHODOLOGY

This longitudinal observational study included 220 patients with DFUs treated at a tertiary care hospital in Chennai. Data were collected on demographics, ulcer severity (Wagner Grade), glycemic status (HbA1c), biochemical markers (C-reactive protein [CRP], interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α], and serum albumin), and clinical outcomes. Statistical analyses were performed using regression and correlation models to assess associations with time to ulcer healing.

RESULTS

HbA1c showed a significant correlation with Wagner Grade but did not independently predict healing time. Serum albumin and Wagner Grade emerged as significant predictors of healing duration ( < 0.05). Although inflammatory markers such as CRP, IL-6, and TNF-α were elevated in many patients, they did not show a statistically significant correlation with healing outcomes.

CONCLUSIONS

DFU healing is a multifactorial process influenced by nutritional status and ulcer severity in addition to glycemic control. Integrating assessments such as Wagner Grade and serum albumin with traditional glycemic markers can enhance the prediction of healing outcomes and guide more effective management strategies.

摘要

背景

糖尿病足溃疡(DFU)是糖尿病最使人衰弱的并发症之一,常导致愈合延迟、感染以及潜在的肢体丧失。虽然通常通过糖化血红蛋白(HbA1c)来衡量的血糖控制一直是DFU管理的主要重点,但最近的证据表明,愈合结果受更广泛因素的影响。

目的

评估除HbA1c之外的临床、生化和炎症参数在DFU愈合中的预测作用。

方法

这项纵向观察性研究纳入了在金奈一家三级护理医院接受治疗的220例DFU患者。收集了有关人口统计学、溃疡严重程度(瓦格纳分级)、血糖状态(HbA1c)、生化标志物(C反应蛋白[CRP]、白细胞介素-6[IL-6]、肿瘤坏死因子-α[TNF-α]和血清白蛋白)以及临床结果的数据。使用回归和相关模型进行统计分析,以评估与溃疡愈合时间的关联。

结果

HbA1c与瓦格纳分级显示出显著相关性,但不能独立预测愈合时间。血清白蛋白和瓦格纳分级成为愈合持续时间的显著预测因素(<0.05)。尽管许多患者的炎症标志物如CRP、IL-6和TNF-α升高,但它们与愈合结果没有显示出统计学上的显著相关性。

结论

DFU愈合是一个多因素过程,除血糖控制外,还受营养状况和溃疡严重程度的影响。将瓦格纳分级和血清白蛋白等评估与传统血糖标志物相结合,可以提高对愈合结果的预测,并指导更有效的管理策略。

相似文献

3
Growth factors for treating diabetic foot ulcers.
Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD008548. doi: 10.1002/14651858.CD008548.pub2.
4
Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes.
Cochrane Database Syst Rev. 2021 Feb 8;2(2):CD012835. doi: 10.1002/14651858.CD012835.pub2.
5
Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Analysis.
Adv Wound Care (New Rochelle). 2024 Sep 5. doi: 10.1089/wound.2023.0167.
6
Topical antimicrobial agents for treating foot ulcers in people with diabetes.
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2.
7
[Study on effectiveness and changes in immunoglobulin levels of transverse tibial transport in treatment of Wagner grade 3-4 type 2 diabetic foot ulcer].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Aug 15;39(8):1030-1036. doi: 10.7507/1002-1892.202503077.
8
Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.
Front Endocrinol (Lausanne). 2023 Nov 18;14:1256081. doi: 10.3389/fendo.2023.1256081. eCollection 2023.
9
Dressings and topical agents for treating venous leg ulcers.
Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2.
10
Hyperbaric oxygen therapy for chronic wounds.
Cochrane Database Syst Rev. 2004(2):CD004123. doi: 10.1002/14651858.CD004123.pub2.

本文引用的文献

1
Diabetic Foot Ulcers and Their Recurrence.
N Engl J Med. 2017 Jun 15;376(24):2367-2375. doi: 10.1056/NEJMra1615439.
2
A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes.
Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:119-41. doi: 10.1002/dmrr.2246.
4
New developments in diagnosing and treating diabetic foot infections.
Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S66-71. doi: 10.1002/dmrr.828.
7
Risk factors for foot infections in individuals with diabetes.
Diabetes Care. 2006 Jun;29(6):1288-93. doi: 10.2337/dc05-2425.
8
Wound healing and treatments for people with diabetic foot ulcers.
Diabetes Metab Res Rev. 2004 May-Jun;20 Suppl 1:S78-89. doi: 10.1002/dmrr.476.
10
Diabetic foot ulcers.
Lancet. 2003 May 3;361(9368):1545-51. doi: 10.1016/S0140-6736(03)13169-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验